CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Patient-reported outcomes measuring an individual’s overall self-rated health after long-term treatment with bulevirtide 2 mg for chronic hepatitis delta in the phase 3 MYR301 trial
DOI 10.1055/s-0045-1810985
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Buti, H Wedemeyer, S Aleman, V Chulanov, V Morozov, O Sagalova, T Stepanova, R G Gish, A Lloyd, K Deterding, D Manuilov, A H Lau, A O Osinusi, M Rock, C Kim, S Pandey, B Singh, P Lampertico
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2025
Jahrgang / SeitenJg. 63 · S. e556
Kernaussage aus der Literatur
Abstract-Vorschau
Patient-reported outcomes measuring an individual’s overall self-rated health after long-term treatment with bulevirtide 2 mg for chronic hepatitis delta in the phase 3 MYR301 trial
Zitieren
Zitierempfehlung
M Buti, H Wedemeyer, S Aleman, V Chulanov, V Morozov, O Sagalova, T Stepanova, R G Gish, A Lloyd, K Deterding, D Manuilov, A H Lau, A O Osinusi, M Rock, C Kim, S Pandey, B Singh, P Lampertico (2025) Patient-reported outcomes measuring an individual’s overall self-rated health after long-term treatment with bulevirtide 2 mg for chronic hepatitis delta in the phase 3 MYR301 trial. Zeitschrift für Gastroenterologie, 63 (08), e556. https://doi.org/10.1055/s-0045-1810985
Mit CareLit weiterarbeiten